| scholarly article | Q13442814 |
| P50 | author | Peter Devilee | Q37361664 |
| Antonis C Antoniou | Q89766295 | ||
| P2093 | author name string | Andrew Lee | |
| Maryam Kavousi | |||
| Bruno H Stricker | |||
| André G Uitterlinden | |||
| Marjanka K Schmidt | |||
| Jeroen van Rooij | |||
| Rikje Ruiter | |||
| Mar Rodríguez-Girondo | |||
| Inge M M Lakeman | |||
| Sara R A Wijnant | |||
| P2860 | cites work | A global reference for human genetic variation | Q25909434 |
| Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics | Q33330850 | ||
| A reference panel of 64,976 haplotypes for genotype imputation | Q33553419 | ||
| On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data | Q33870074 | ||
| The benefits and harms of breast cancer screening: an independent review | Q34309421 | ||
| Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade | Q34378972 | ||
| Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study | Q35532803 | ||
| Genetic predisposition to ductal carcinoma in situ of the breast | Q35925620 | ||
| Prediction of breast cancer risk based on profiling with common genetic variants | Q36583004 | ||
| Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications. | Q39263736 | ||
| Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States | Q39734134 | ||
| Breast Cancer Epidemiology and Risk Factors | Q40532531 | ||
| Overdiagnosis by mammographic screening for breast cancer studied in birth cohorts in The Netherlands. | Q41542291 | ||
| Breast cancer diagnosis and death in the Netherlands: a changing burden. | Q44025217 | ||
| Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study. | Q47151886 | ||
| Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction. | Q49964811 | ||
| Common breast cancer risk alleles and risk assessment: a study on 35 441 individuals from the Danish general population. | Q50574525 | ||
| The benefits and harms of breast cancer screening: an independent review | Q57131263 | ||
| Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model | Q57177092 | ||
| Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes | Q62583133 | ||
| 10-year performance of four models of breast cancer risk: a validation study | Q64115284 | ||
| Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018 | Q90903275 | ||
| BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors | Q91045517 | ||
| Cancer genetics, precision prevention and a call to action | Q91211233 | ||
| Predictors of an Invasive Breast Cancer Recurrence after DCIS: A Systematic Review and Meta-analyses | Q91521771 | ||
| Objectives, design and main findings until 2020 from the Rotterdam Study | Q94522957 | ||
| P577 | publication date | 2020-07-06 | |
| P1433 | published in | Genetics in Medicine | Q15765508 |
| P1476 | title | Validation of the BOADICEA model and a 313-variant polygenic risk score for breast cancer risk prediction in a Dutch prospective cohort |
Search more.